Alio WEAR Study: Long-term Wear of the Alio Platform

NCT06056739 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2023-10-11

No results posted yet for this study

Summary

The WEAR study is long-term interventional study designed to evaluate patient and clinician use of the Alio platform, per its FDA cleared indications.

Conditions

Interventions

DEVICE

Alio platform

Remote monitoring platform

Sponsors & Collaborators

  • Alio, Inc.

    lead INDUSTRY

Principal Investigators

  • David Whittaker, MD · Alio

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2024-04-01
Completion
2024-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06056739 on ClinicalTrials.gov